Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: Findings from the CRIC study

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Amdur, Richard L ^a,d   Mukherjee, Monica ^b   Go, Alan ^c   Barrows, Ian R ^d   Ramezani, Ali ^d   Shoji, Jun ^d   Reilly, Muredach P ^e   Gnanaraj, Joseph ^f   Deo, Raj ^e   Roas, Sylvia ^g   Keane, Martin ^h   Master, Steve ⁱ   Teal, Valerie ⁱ   Soliman, Elsayed Z ^j   Yang, Peter ⁱ   Feldman, Harold ⁱ   Kusek, John W ^k   Tracy, Cynthia M ^d   Raj, Dominic S ^d   Appel, Lawrence J ^b   He, Jiang ^l   Lash, James P ^m   Ojo, Akinlolu ⁿ   Rahman, Mahboob ^o   Townsend, Raymond R ^e   more..

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BRIDGEPORT HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^l TULANE UNIVERSITY   (United States)

^m UNIVERSITY OF ILLINOIS   (United States)

ⁿ UNIVERSITY OF MICHIGAN   (United States)

^o UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; IL1RN PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ETHNICITY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SELF REPORT; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; ELECTROCARDIOGRAPHY; FOLLOW UP; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY;

ADULT; AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959016718     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148189     Document Type: Article

References (52)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375. jcc10004 [pii]. PMID: 11343485
2. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL et al. (2001) ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 104: 2118-2150. PMID: 11673357
3. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22: 983-988. PMID: 1866765
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98: 946-952. PMID: 9737513
5. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Seward JB et al. (2008) Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. Am J Cardiol 102: 568-572. S0002-9149(08)00749-2 [pii]; doi: 10.1016/j.amjcard.2008.04.025 PMID: 18721513
6. Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellanWet al. (2011) Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol 4: 26-32. CIRCEP.110.957100 [pii]; doi: 10.1161/CIRCEP.110.957100 PMID: 21076159
7. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F et al. (2005) Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46: 897-902. S0272-6386(05)01055-3 [pii]; doi: 10.1053/j.ajkd.2005.07.044 PMID: 16253730
8. Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY et al. (2011) Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123: 2946-2953. CIRCULATIONAHA.111.020982 [pii]; doi: 10.1161/CIRCULATIONAHA.111.020982 PMID: 21646496
9. Nelson SE, Shroff GR, Li S, Herzog CA (2012) Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients. J Am Heart Assoc 1: e002097. doi: 10.1161/JAHA.112.002097 jah371 [pii]. PMID: 23130165
10. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS (2013) Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 127: 569-574. CIRCULATIONAHA. 112.123992 [pii]; doi: 10.1161/CIRCULATIONAHA.112.123992 PMID: 23275377
11. Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder? Eur Heart J 27: 136-149. ehi645 [pii]; doi: 10.1093/eurheartj/ehi645 PMID: 16278230
12. Marott SC, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjaerg-Hansen A et al. (2010) Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. J Am Coll Cardiol 56: 789-795. S0735-1097(10)02305-3 [pii]; doi: 10.1016/j.jacc.2010.02.066 PMID: 20797493
13. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE (2008) Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J 155: 303-309. S0002-8703(07)00764-8 [pii]; doi: 10.1016/j.ahj.2007.09.006 PMID: 18215601
14. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM et al. (2010) Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7: 438-444. S1547-5271(09)01380-0 [pii]; doi: 10.1016/j. hrthm.2009.12.009 PMID: 20153266
15. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M et al. (2012) Association between albuminuria, kidney function, and inflammatory biomarker profile. Clin J Am Soc Nephrol 7: 1938-1946. CJN.03500412 [pii]; doi: 10.2215/CJN.03500412 PMID: 23024164
16. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J et al. (2003) The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 14: S148-S153. PMID: 12819321
17. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M et al. (2009) Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4: 1302-1311. CJN.00070109 [pii]; doi: 10.2215/CJN.00070109 PMID: 19541818
18. Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D et al. (2012) Estimating GFR Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 60: 250-261. S0272-6386(12)00674-9 [pii]; doi: 10.1053/j.ajkd.2012.04.012 PMID: 22658574
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463. S0894-7317(05)00983-1 [pii]; doi: 10.1016/j.echo.2005.10.005 PMID: 16376782
20. Prineas RJ, Crow RS, Blackburn H (1982) The Minnesota Code Manual of Electrocardiographic Findings.
21. Allison PD (1999) Logistic regression using SAS: Theory and application.
22. McManus DD, Corteville DC, Shlipak MG, Whooley MA, Ix JH (2009) Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). Am J Cardiol 104: 1551-1555. S0002-9149(09)01392-7 [pii]; doi: 10.1016/j.amjcard.2009.07.026 PMID: 19932791
23. Deo R, Katz R, Kestenbaum B, Fried L, Sarnak MJ, Psaty BM et al. (2010) Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail 16: 55-60. S1071-9164(09)00653-8 [pii]; doi: 10. 1016/j.cardfail.2009.07.002 PMID: 20123319
24. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M et al. (2010) Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 159: 1102-1107. S0002-8703(10)00253-X [pii]; doi: 10.1016/j.ahj.2010.03.027 PMID: 20569726
25. Ehrlich JR, Hohnloser SH, Nattel S (2006) Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 27: 512-518. ehi668 [pii]; doi: 10. 1093/eurheartj/ehi668 PMID: 16311236
26. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N et al. (2009) Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20: 933-939. ASN.2008040402 [pii]; doi: 10.1681/ASN.2008040402 PMID: 18799718
27. Gupta J, Dominic EA, Fink JC, Ojo AO, Barrows IR, Reilly MP et al. (2015) Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One 10: e0124772. doi: 10.1371/journal.pone.0124772 PONE-D-14-55447 [pii]. PMID: 25909952
28. Wing MR, Yang W, Teal V, Navaneethan S, Tao K, Ojo A et al. (2014) Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: Findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring). doi: 10.1002/oby.20692
29. Raj DS, Dominic EA, Pai A, Osman F, Morgan M, Pickett G et al. (2005) Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int 68: 2338-2344. KID695 [pii]; doi: 10.1111/j. 1523-1755.2005.00695.x PMID: 16221238
30. Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2: d12-d26. PMID: 9159205
31. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96: 1180-1184. PMID: 9286947
32. Lee SH, Chen YC, Chen YJ, Chang SL, Tai CT, WongcharoenWet al. (2007) Tumor necrosis factoralpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 80: 1806-1815. S0024-3205(07)00195-6 [pii]; doi: 10.1016/j.lfs.2007.02.029 PMID: 17383682
33. Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, Cook NR et al. (2010) A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 31: 1730-1736. ehq146 [pii]; doi: 10.1093/eurheartj/ehq146 PMID: 20501475
34. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA et al. (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108: 3006-3010. doi: 10.1161/01.CIR. 0000103131.70301.4F 01.CIR.0000103131.70301.4F [pii]. PMID: 14623805
35. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB et al. (2010) Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121: 200-207. CIRCULATIONAHA.109.882241 [pii]; doi: 10.1161/CIRCULATIONAHA. 109.882241 PMID: 20048208
36. Ananthapanyasut W, Napan S, Rudolph EH, Harindhanavudhi T, Ayash H, Guglielmi KE et al. (2010) Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 173-181. CJN.03170509 [pii]; doi: 10.2215/CJN.03170509 PMID: 20007681
37. Raj DS, Moseley P, Dominic EA, Onime A, Tzamaloukas AH, Boyd A et al. (2008) Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis. Kidney Int 73: 1054-1061. ki200821 [pii]; doi: 10.1038/ki.2008.21 PMID: 18288103
38. Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G et al. (2010) Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost 104: 122-127. 09-12-0837 [pii]; doi: 10.1160/TH09-12-0837 PMID: 20458440
39. Leftheriotis DI, Fountoulaki KT, Flevari PG, Parissis JT, Panou FK, Andreadou IT et al. (2009) The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation. Int J Cardiol 135: 361-369. S0167-5273(08)00563-9 [pii]; doi: 10.1016/j.ijcard. 2008.04.012 PMID: 18640731
40. Henningsen KM, Nilsson B, Bruunsgaard H, Chen X, Pedersen BK, Svendsen JH (2009) Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Scand Cardiovasc J 43: 285-291. 907307162 [pii]; doi: 10.1080/14017430802653676 PMID: 19117239
41. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT (2005) Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95: 764-767. S0002-9149(04)01885-5 [pii]; doi: 10.1016/j.amjcard. 2004.11.032 PMID: 15757607
42. Raymond RJ, Dehmer GJ, Theoharides TC, Deliargyris EN (2001) Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141: 435-438. S0002-8703 (01)95658-3 [pii]; doi: 10.1067/mhj.2001.113078 PMID: 11231442
43. Kerr R, Stirling D, Ludlam CA (2001) Interleukin 6 and haemostasis. Br J Haematol 115: 3-12. 3061 [pii]. PMID: 11722403
44. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772. PMID: 10769275
45. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr. et al. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106: 506-512. S0002934399000662 [pii]. PMID: 10335721
46. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S et al. (1998) Immunologic function and survival in hemodialysis patients. Kidney International 54: 236-244. PMID: 9648084
47. Rao M, Guo D, Perianayagam MC, Tighiouart H, Jaber BL, Pereira BJ et al. (2005) Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 45: 324-333. PMID: 15685511
48. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD, Tribouilloy C et al. (2010) Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 77: 550-556. ki2009503 [pii]; doi: 10.1038/ki.2009.503 PMID: 20016471
49. Zoccali C, Tripepi G, Mallamaci F (2006) Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 17: S169-S173. 17/12-suppl-3/S169 [pii]; doi: 10.1681/ASN.2006080910 PMID: 17130257
50. Yan AT, Yan RT, Cushman M, Redheuil A, Tracy RP, Arnett DK et al. (2010) Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis. Eur Heart J 31: 875-882. ehp454 [pii]; doi: 10.1093/eurheartj/ehp454 PMID: 20064818
51. Jones SA, Scheller J, Rose-John S (2011) Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121: 3375-3383. 57158 [pii]; doi: 10.1172/JCI57158 PMID: 21881215
52. Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR et al. (2012) Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev 21: 1167-1170. 1055-9965.EPI-12-0110 [pii]; doi: 10.1158/1055-9965.EPI-12-0110 PMID: 22564866